Browsing by Author Chakravarthy, Usha

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2010Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysisMitchell, Paul (Ronald); Buggage, Ronald; Chakravarthy, Usha; Evans, Christopher; Fletcher, Astrid; Piault, Elisabeth; Pleil, Andreas; Wong, Tien Y.; Zlateva, Gergana; Western Clinical School: Westmead Millennium InstituteClinical risk factors for age-related macular degeneration: a systematic review and meta-analysis, BMC Ophthalmology, vol.10, N/A,pp 31-N/A
2007The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration: A Systematic Review of the Literature and Meta-analysisMitchell, Paul (Ronald); Buggage, Ronald; Chakravarthy, Usha; Fahrbach, Kyle; Klein, Ronald; Probst, Corey; Sledge, Isabella; Wong, Tien; Zlateva, Gergana; Western Clinical School: Westmead Millennium InstituteThe Natural History and Prognosis of Neovascular Age-Related Macular Degeneration: A Systematic Review of the Literature and Meta-analysis, Ophthalmology: journal of the American Academy of Ophthalmology, vol.Published online: August 6, 2007,(1),2007,pp 116-126
2015UK AMD EMR USERS GROUP REPORT V: Benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12Liew, Gerald; Akerele, Toks; Butt, Thomas; Chakravarthy, Usha; Downey, Louise; Egan, Catherine; et al, Various; Johnston, Robert; Lee, Aaron; Lee, Cecilia; McKibbin, Martin; Xing, Wen; Western Clinical School: Clinical Ophthal & Eye HealthUK AMD EMR USERS GROUP REPORT V: Benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12, British Journal of Ophthalmology, vol.99, 8, 2015,pp 1045-1050